Finance

Beta
Lists
002603:SHE
Shijiazhuang Yiling Pharmaceuticl Co Ltd
CNÂ¥15.40
+1.52%
(+0.23) 1D
Jun 5, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002603...
Open
CNÂ¥15.25
High
CNÂ¥15.59
Low
CNÂ¥15.25
Mkt. cap
25.34B
Avg. vol.
16.06M
Volume
12.42M
P/E ratio
18.79
52-wk high
CNÂ¥21.58
52-wk low
CNÂ¥13.78
EPS
CNÂ¥0.82
Shares outstanding
1.67B
No. of employees
11K
Open
CNÂ¥15.25
High
CNÂ¥15.59
Low
CNÂ¥15.25
Mkt. cap
25.34B
Avg. vol.
16.06M
Volume
12.42M
P/E ratio
18.79
52-wk high
CNÂ¥21.58
52-wk low
CNÂ¥13.78
EPS
CNÂ¥0.82
Shares outstanding
1.67B
No. of employees
11K
News stories
From sources across the web
About Shijiazhuang Yiling Pharmaceuticl Co Ltd
CEO-
Employees11.3K
FoundedJun 16, 1992
Headquarters-
SectorPharmaceutical industry
Websiteyiling.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.68B
1.83B
1.96B
2.44B
Cost of goods sold
567.28M
659.61M
558.68M
974.60M
Cost of revenue
567.28M
659.61M
558.68M
974.60M
Research and development expenses
194.25M
185.73M
174.24M
173.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
522.51M
564.05M
748.27M
749.37M
Operating expense
752.68M
775.61M
965.99M
972.94M
Total operating expenses
1.32B
1.44B
1.52B
1.95B
Operating income
361.95M
392.23M
438.46M
492.24M
Other non operating income
-164.78K
-2.04M
-1.72M
-2.14M
EBT including unusual items
409.53M
365.98M
421.98M
489.10M
EBT excluding unusual items
363.34M
391.80M
437.85M
494.81M
Income tax expense
68.39M
34.61M
136.92M
80.49M
Effective tax rate
16.70%
9.46%
32.45%
16.46%
Other operating expenses
34.56M
30.07M
28.77M
42.45M
Net income
342.58M
331.87M
286.07M
408.85M
Net profit margin
20.37%
18.16%
14.57%
16.76%
Earnings per share
-
-
-
-
Interest and investment income
1.98M
1.81M
3.33M
5.07M
Interest expense
-262.01K
-358.83K
-302.73K
-361.45K
Net interest expenses
1.72M
1.45M
3.03M
4.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
510.43M
542.37M
592.20M
645.98M
Gain or loss from assets sale
-14.19K
14.19K
887.25K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer